idra 21 has been researched along with diazoxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolino, M; Costa, E; DiBella, M; Guidotti, A; Thompson, DM; Uzunov, D; Zivkovic, I | 1 |
| Covey, DF; He, YY; Hsu, CY; Hu, R; Hu, Y; Yamada, KA | 1 |
| Baraldi, M; Braghiroli, D; Di Bella, M; Losi, G; Puia, G; Razzini, G | 1 |
3 other study(ies) available for idra 21 and diazoxide
| Article | Year |
|---|---|
7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
Topics: Alprazolam; Animals; Avoidance Learning; Benzothiadiazines; Brain; Chlorothiazide; Cognition; Diazoxide; Electrophysiology; Glutamates; Ligands; Male; Maze Learning; Phosphatidylinositols; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Muscarinic; Scopolamine; Stereoisomerism; Synaptosomes | 1995 |
The diazoxide derivative IDRA 21 enhances ischemic hippocampal neuron injury.
Topics: Animals; Benzothiadiazines; Brain Ischemia; Cells, Cultured; Diazoxide; Diuretics; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Nerve Degeneration; Neurons; Neurotoxins; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, AMPA; Sodium Chloride Symporter Inhibitors | 1998 |
Modulation of kainate--activated currents by diazoxide and cyclothiazide analogues (IDRA) in cerebellar granule neurons.
Topics: Action Potentials; Animals; Benzothiadiazines; Cerebellum; Diazoxide; Electrophysiology; Kainic Acid; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Vasodilator Agents | 2000 |